Macrogen, Inc. (KOSDAQ:038290)
South Korea · Delayed Price · Currency is KRW 11,960
-60 (-0.50%)
Sep 10, 2026, 9:34 AM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 130.31 billion as of September 9, 2026. Its market cap has decreased by -23.63% in one year.
Market Cap
130.31B
Enterprise Value
176.81B
Revenue
201.62B
Ranking
n/a
PE Ratio
12.66
Stock Price
11,960.00
ChartMarket Cap Chart
Since September 14, 2000, Macrogen's market cap has decreased from 148.29B to 130.31B, a decrease of -12.12%. That is a compound annual growth rate of -0.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 130.31B | -28.75% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 67.14T |
| Celltrion | 43.94T |
| ALTEOGEN | 19.46T |
| Samsung Epis Holdings | 8.64T |
| Helixmith | 140.44B |
| Dong Sung Bio Pharm.Co.,Ltd. | 137.45B |
| Genexine | 134.62B |
| Kyongbo Pharmaceutical | 129.10B |